Michael B. Hoffman net worth and biography

Michael Hoffman Biography and Net Worth

Director of Annovis Bio

Mr. Hoffman is the Founder and Managing Partner of Stone Capital Partners, a private equity firm focused on power and renewable energy. He was Partner of Riverstone, senior managing director at the Blackstone Group and managing director at Smith Barney, Harris Upham & Co. He serves as President of Northern Genesis Acquisition Corporation (II and III) and is a Trustee of The Rockefeller University.

‍

What is Michael B. Hoffman's net worth?: The estimated net worth of Michael B. Hoffman is at least $4.29 million as of May 20th, 2026. Mr. Hoffman owns 3,364,883 shares of Annovis Bio stock worth more than $4,290,226 as of September 23rd. This net worth evaluation does not reflect any other assets that Mr. Hoffman may own. Learn More about Michael B. Hoffman's net worth.
How do I contact Michael B. Hoffman?: The corporate mailing address for Mr. Hoffman and other Annovis Bio executives is 101 Lindenwood Drive, Suite 225, Malvern, PA, 19355. Annovis Bio can also be reached via phone at (484) 875-3192 and via email at [email protected]. Learn More on Michael B. Hoffman's contact information.
Has Michael B. Hoffman been buying or selling shares of Annovis Bio?: Michael B. Hoffman has not been actively trading shares of Annovis Bio over the course of the past ninety days. Most recently, on Wednesday, May 20th, Michael B. Hoffman bought 76,344 shares of Annovis Bio stock. The stock was acquired at an average cost of $1.87 per share, with a total value of $142,763.28. Following the completion of the transaction, the director now directly owns 3,364,883 shares of the company's stock, valued at $6,292,331.21. Learn More on Michael B. Hoffman's trading history.
Who are Annovis Bio's active insiders?: Annovis Bio's insider roster includes Claudine Bruck (Director), Michael Hoffman (Director), Maria-Luisa Maccecchini (CEO), and Reid McCarthy (Director). Learn More on Annovis Bio's active insiders.
Are insiders buying or selling shares of Annovis Bio?: During the last year, Annovis Bio insiders bought shares 8 times. They purchased a total of 1,982,515 shares worth more than $4,297,279.83. The most recent insider tranaction occured on May, 20th when Director Michael B. Hoffman bought 76,344 shares worth more than $142,763.28. Insiders at Annovis Bio own 15.9% of the company. Learn More about insider trades at Annovis Bio.
Information on this page was last updated on 5/20/2026.

Michael B. Hoffman Insider Trading History at Annovis Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/20/2026	Buy	76,344	$1.87	$142,763.28	3,364,883
4/2/2026	Buy	713,800	$2.10	$1,498,980.00	3,288,539
12/8/2025	Buy	45,000	$4.31	$193,950.00	2,574,739
11/24/2025	Buy	39,200	$4.08	$159,936.00	2,519,739
11/21/2025	Buy	20,000	$3.50	$70,000.00	2,490,539
11/14/2025	Buy	15,000	$2.11	$31,650.00	2,470,539
10/28/2025	Buy	975,610	$2.05	$2,000,000.50	2,455,539

Michael B. Hoffman Buying and Selling Activity at Annovis Bio

Annovis Bio Company Overview

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.

Today's Range

Now: $1.28

$1.24

$1.33

50 Day Range

MA: $1.62

$1.08

$1.89

2 Week Range

Now: $1.28

$1.04

$5.50

Volume

1,144,008 shs

Average Volume

868,755 shs

Market Capitalization

$54.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24